BR112019014418A2 - composições probióticas e usos das mesmas - Google Patents
composições probióticas e usos das mesmas Download PDFInfo
- Publication number
- BR112019014418A2 BR112019014418A2 BR112019014418-8A BR112019014418A BR112019014418A2 BR 112019014418 A2 BR112019014418 A2 BR 112019014418A2 BR 112019014418 A BR112019014418 A BR 112019014418A BR 112019014418 A2 BR112019014418 A2 BR 112019014418A2
- Authority
- BR
- Brazil
- Prior art keywords
- cells
- lactobacillus
- fact
- petition
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1700542.2A GB201700542D0 (en) | 2017-01-12 | 2017-01-12 | Probiotic compositions and uses thereof |
| GB1700542.2 | 2017-01-12 | ||
| GBGB1709731.2A GB201709731D0 (en) | 2017-06-19 | 2017-06-19 | Probiotic compositions and uses thereof |
| GB1709731.2 | 2017-06-19 | ||
| PCT/EP2018/050789 WO2018130667A1 (en) | 2017-01-12 | 2018-01-12 | Probiotic compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019014418A2 true BR112019014418A2 (pt) | 2020-04-14 |
Family
ID=61386800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019014418-8A BR112019014418A2 (pt) | 2017-01-12 | 2018-01-12 | composições probióticas e usos das mesmas |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11166993B2 (https=) |
| EP (1) | EP3568144B1 (https=) |
| JP (1) | JP7089523B2 (https=) |
| KR (1) | KR102500496B1 (https=) |
| CN (1) | CN110177561B (https=) |
| AU (1) | AU2018207946B2 (https=) |
| BR (1) | BR112019014418A2 (https=) |
| CA (1) | CA3049624A1 (https=) |
| CL (1) | CL2019001938A1 (https=) |
| MX (1) | MX2019008292A (https=) |
| MY (1) | MY195253A (https=) |
| PH (1) | PH12019501629A1 (https=) |
| RU (1) | RU2763311C2 (https=) |
| WO (1) | WO2018130667A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112584848A (zh) * | 2018-06-18 | 2021-03-30 | 普罗比公司 | 益生菌组合物及其用途 |
| IT201900014550A1 (it) * | 2019-08-09 | 2021-02-09 | Abiogen Pharma Spa | Uso di colecalciferolo come agente attivo nel trattamento della celiachia |
| CN116869141A (zh) * | 2022-05-05 | 2023-10-13 | 内蒙古一康健康发展有限责任公司 | 一种具有保健功能的益生菌复合物及其制备方法 |
| KR102845919B1 (ko) * | 2023-02-28 | 2025-08-14 | 주식회사 피엘비앤비 | 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물 |
| CN119279210A (zh) * | 2024-12-16 | 2025-01-10 | 山东健源生物科技有限公司 | 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076615A2 (en) * | 2003-02-27 | 2004-09-10 | Bioneer A/S | Immunomodulating probiotic compounds |
| WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
| ZA200802934B (en) * | 2005-10-06 | 2009-09-30 | Probi Ab | Use of lactobacillus for treatment of virus infections |
| AU2006297896B2 (en) | 2005-10-06 | 2011-12-08 | Probi Ab | Use of lactobacillus for treatment of autoimmune diseases |
| DK1996696T3 (en) | 2006-03-17 | 2017-03-20 | Probi Ab | Thermostable lactobacillus strains |
| WO2007108763A1 (en) | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
| CN102438643B (zh) | 2008-11-30 | 2015-07-01 | 免疫桑特公司 | 用于治疗乳糜泻的组合物和方法 |
| EP2581461B1 (en) * | 2011-10-14 | 2014-09-24 | GenMont Biotech Incorporation | Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
| ES3010649T3 (en) | 2012-06-18 | 2025-04-04 | Heinz Co Brands H J Llc | Gluten-related disorders |
| US10245290B2 (en) * | 2013-04-03 | 2019-04-02 | Probi Ab | Probiotic strains for use in treatment or prevention of osteoporosis |
| ES2764210T3 (es) * | 2014-11-25 | 2020-06-02 | Dsm Ip Assets Bv | Lactobacillus para usar como probiótico |
-
2018
- 2018-01-12 BR BR112019014418-8A patent/BR112019014418A2/pt active Search and Examination
- 2018-01-12 MY MYPI2019003890A patent/MY195253A/en unknown
- 2018-01-12 JP JP2019538207A patent/JP7089523B2/ja active Active
- 2018-01-12 AU AU2018207946A patent/AU2018207946B2/en active Active
- 2018-01-12 CA CA3049624A patent/CA3049624A1/en active Pending
- 2018-01-12 CN CN201880006818.0A patent/CN110177561B/zh active Active
- 2018-01-12 RU RU2019121145A patent/RU2763311C2/ru active
- 2018-01-12 MX MX2019008292A patent/MX2019008292A/es unknown
- 2018-01-12 WO PCT/EP2018/050789 patent/WO2018130667A1/en not_active Ceased
- 2018-01-12 US US16/477,259 patent/US11166993B2/en active Active
- 2018-01-12 KR KR1020197022803A patent/KR102500496B1/ko active Active
- 2018-01-12 EP EP18707627.8A patent/EP3568144B1/en active Active
-
2019
- 2019-07-11 CL CL2019001938A patent/CL2019001938A1/es unknown
- 2019-07-12 PH PH12019501629A patent/PH12019501629A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2763311C2 (ru) | 2021-12-28 |
| US20190358275A1 (en) | 2019-11-28 |
| WO2018130667A1 (en) | 2018-07-19 |
| EP3568144C0 (en) | 2024-05-08 |
| CL2019001938A1 (es) | 2019-09-27 |
| CA3049624A1 (en) | 2018-07-19 |
| AU2018207946A1 (en) | 2019-07-25 |
| AU2018207946B2 (en) | 2024-07-18 |
| RU2019121145A3 (https=) | 2021-04-26 |
| EP3568144A1 (en) | 2019-11-20 |
| RU2019121145A (ru) | 2021-02-12 |
| JP7089523B2 (ja) | 2022-06-22 |
| US11166993B2 (en) | 2021-11-09 |
| JP2020513780A (ja) | 2020-05-21 |
| CN110177561B (zh) | 2023-09-12 |
| EP3568144B1 (en) | 2024-05-08 |
| KR20190104568A (ko) | 2019-09-10 |
| MX2019008292A (es) | 2019-09-16 |
| MY195253A (en) | 2023-01-11 |
| PH12019501629A1 (en) | 2020-06-01 |
| CN110177561A (zh) | 2019-08-27 |
| KR102500496B1 (ko) | 2023-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miyazawa et al. | Heat-killed Lactobacillus gasseri can enhance immunity in the elderly in a double-blind, placebo-controlled clinical study | |
| US11166993B2 (en) | Methods for celiac disease using lactobacillus strains | |
| Renner et al. | Comel-Netherton syndrome defined as primary immunodeficiency | |
| EP3552613B1 (en) | Composition for inducing proliferation or accumulation of regulatory t cells | |
| Medina et al. | Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients | |
| Kaukinen et al. | Coeliac disease-a diagnostic and therapeutic challenge. | |
| Wang et al. | Intestinal microbiota profiles of healthy pre-school and school-age children and effects of probiotic supplementation | |
| US20180193391A1 (en) | Induction of lamina propria regulatory t cells | |
| US20150104423A1 (en) | Use of blood group status iii | |
| EP2598155A2 (en) | Use of blood group status iii | |
| US11590181B2 (en) | Serpin production | |
| AU2020299976B2 (en) | Serpin production | |
| WO2019129807A1 (en) | Serpin production | |
| Zhao | Immune responses alter in heterogeneous nuclear ribonucleoprotein I knockout mice with medium protein diet or probiotic intervention | |
| Tochio et al. | Changes in the Intestinal Microbiota and Systemic Immune Responses by Dietary 1-Kestose Supplementation in Healthy Dogs. | |
| HK40075389B (en) | Composition for inducing proliferation or accumulation of regulatory t cells | |
| HK40075389A (en) | Composition for inducing proliferation or accumulation of regulatory t cells | |
| Pozo-Rubio et al. | Pozo-Rubio T et al. Br J Nutr. 2011 Oct; 106 (8): 1216-23 | |
| Hungerford | Coeliac disease | |
| Lahdenperä | Studies of Mucosal Immune Regulation in Celiac Disease and Type 1 Diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B25G | Requested change of headquarter approved |
Owner name: PROBI AB (SE) |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] |